Iovance Biotherapeutics, Inc. Ratios

1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2009 Dec2010 Dec2011 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -804.54%24.43%
EBT Margin 14,104.84%5,190.97%-212,532.51%-37,638.02%-228.56%
EBIT Margin 14,004.84%5,090.97%-212,738.52%-38,734.99%-240.92%
EBITDA Margin 14,004.84%5,090.97%-212,738.52%-38,734.99%-240.92%
Operating Margin 14,004.84%5,090.97%-212,738.52%-38,734.99%-240.92%
Net Margin 14,104.84%7,610.03%-212,632.51%-37,343.65%-226.84%
FCF Margin 4,105.59%826.12%-180,653.71%-32,305.30%-221.90%
Efficiency
Inventory Average 30.95M
Assets Average 1.01M10.22M33.19M76.08M138.77M163.63M318.10M845.39M
Equity Average 0.31M-6.07M2.41M31.22M74.43M135.47M156.20M305.84M647.51M
Invested Capital -0.01M1.43M-4.84M17.60M44.84M104.02M166.92M145.48M466.19M584.61M710.40M
Asset Utilization Ratio -0.15-0.040.000.19
Leverage & Solvency
Interest Coverage Ratio -0.02-140.05-50.910.00M
Debt to Equity 1.24-0.620.000.00
Debt Ratio 0.5413.960.000.00
Equity Ratio 0.44-22.480.890.960.980.970.940.970.750.78
Times Interest Earned -140.05-50.910.00M
Valuation
Enterprise Value -0.01M-1.30M-0.52M-19.67M-44.91M265.58M265.03M435.69M621.53M2,995.20M1,008.60M1,800.75M1,931.60M
Market Capitalization 369.28M431.50M581.06M1,090.05M2,995.20M1,008.60M2,080.62M2,255.38M
Return Ratios
Return on Sales 141.05%51.91%-373.44%-2.27%
Return on Capital Employed 1.72%-2.85%-0.38%-0.37%-0.40%-0.60%-0.42%-0.55%
Return on Invested Capital -0.61%
Return on Assets -21.06%-2.26%-0.36%-0.36%-0.38%-0.56%-0.39%-0.44%
Return on Equity -2.61%3.52%-9.58%-0.39%-0.37%-0.39%-0.59%-0.40%-0.57%